AQST
Aquestive Therapeutics, Inc. Common Stock#72 · 2024EPBYearly return
+77%
Peak return
+210%
Max drawdown
-64%
ADR (20 days)
+6.1%
Base
22 days / -21.4%
Prior run
+117%
Breakout volume
3.8x
Pivot
$2.95
Catalyst Earnings/Guidance2024-03-05Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare AQST with the current market directly.